secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0001437749-25-014527
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics Q1 2025 revenue $3.4M, net loss $2.9M; partnerships expand distribution
--------------------------------------------------------------------------------

- Revenue of $3.4M down 11% YoY ($3.8M); net loss $2.9M ($0.12/sh) vs $3.4M ($0.20/sh) in Q1 2024.
- Gross margin improved to 53.5% from 51.9%; cash used in operations fell 43% to $2.0M.
- Named National Seating & Mobility as exclusive U.S. CRT distributor for Ekso Indego Personal.
- Appointed Bionic Prosthetics & Orthotics Group as first O&P distributor for Ekso Indego Personal.
- Cash and restricted cash $8.1M at March 31, 2025; $3.8M net proceeds from warrant exercises.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000143774925014527/0001437749-25-014527-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000143774925014527/ekso20250318c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-014527

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer